ONCODEcipher Liquid28
Non-invasive NGS panel targeting 28 genes mutation using liquid biopsy (blood) to provide treatment options & prognostic indications
Learn More
Learn More
ONCODEcipher Lung Absolute 2.0
NGS panel targeting 14 genes commonly altered in lung cancer including fusions (ALK, ROS1, MET, RET, NTRK etc.) and mutations (EGFR, KRAS, BRAF, ALK, ERBB2 etc.) Learn More
ONCODEcipher Breast & Ovarian Core28
NGS panel targeting 28 clinically relevant and actionable genes commonly mutated in ALL solid tumours including BRCA1 & 2 (somatic), ESR1, PIK3CA, TP53 and others Learn More
ONCODEcipher Colon Essential67 + MSI
NGS panel targeting 67 relevant genetic mutations (including mutations of RAS/RAF/MEK/MAP kinase signaling pathway) AND microsatellite instability status using tissue biopsy Learn More
ONCODEcipher Microsatellite Instability (MSI)
PCR & Fragment analysis-based assays detecting microsatellite instability status for the discovery of treatment options
Learn More
Learn More
ONCODEcipher BRCA 1&2 Germline + MLPA
NGS panel targeting germline BRCA 1 & 2 mutations (100% coverage) to identify the risk of hereditary breast, ovarian, prostate, pancreatic cancers; and to seek for treatment options Learn More
ONCODEcipher BRAF PCR
PCR-based method to detect BRAF mutation at V600E hotpot in all solid tumours especially in melanoma
Learn More
Learn More
ONCODEcipher Liquid28
Non-invasive NGS panel targeting 28 genes mutation using liquid biopsy (blood) to provide treatment options & prognostic indications
Learn More
Learn More
ONCODEcipher Lung Absolute 2.0
NGS panel targeting 14 genes commonly altered in lung cancer including fusions (ALK, ROS1, MET, RET, NTRK etc.) and mutations (EGFR, KRAS, BRAF, ALK, ERBB2 etc.)
Learn More
Learn More
ONCODEcipher Breast & Ovarian Core28
NGS panel targeting 28 clinically relevant and actionable genes commonly mutated in ALL solid tumours including BRCA1 & 2 (somatic), ESR1, PIK3CA, TP53 and others
Learn More
Learn More
ONCODEcipher Colon Essential67 + MSI
NGS panel targeting 67 relevant genetic mutations (including mutations of RAS/RAF/MEK/MAP kinase signaling pathway) AND microsatellite instability status using tissue biopsy
Learn More
Learn More
ONCODEcipher Microsatellite Instability (MSI)
PCR & Fragment analysis-based assays detecting microsatellite instability status for the discovery of treatment options
Learn More
Learn More
ONCODEcipher BRCA 1&2 Germline + MLPA
NGS panel targeting germline BRCA 1 & 2 mutations (100% coverage) to identify the risk of hereditary breast, ovarian, prostate, pancreatic cancers; and to seek for treatment options
Learn More
Learn More
ONCODEcipher BRAF PCR
PCR-based method to detect BRAF mutation at V600E hotpot in all solid tumours especially in melanoma
Learn More
Learn More